Solventum (NYSE:SOLV) Issues FY 2024 Earnings Guidance

Solventum (NYSE:SOLVGet Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 6.100-6.400 for the period, compared to the consensus EPS estimate of 6.270. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Edward Jones assumed coverage on Solventum in a report on Tuesday, April 2nd. They set a hold rating for the company. Bank of America started coverage on Solventum in a report on Friday. They issued a neutral rating and a $70.00 price target for the company. Wells Fargo & Company started coverage on Solventum in a report on Monday, April 8th. They issued an equal weight rating and a $69.00 price target for the company. Finally, Morgan Stanley started coverage on Solventum in a report on Wednesday, April 10th. They issued an equal weight rating and a $70.00 price target for the company.

View Our Latest Research Report on Solventum

Solventum Price Performance

SOLV stock traded down $1.09 during midday trading on Friday, hitting $63.74. 1,916,241 shares of the company’s stock were exchanged, compared to its average volume of 1,856,665. Solventum has a 1-year low of $60.72 and a 1-year high of $96.05.

Solventum (NYSE:SOLVGet Free Report) last released its quarterly earnings results on Thursday, May 9th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $1.67 by $0.41. The firm had revenue of $2.02 billion for the quarter, compared to analysts’ expectations of $1.99 billion. Sell-side analysts forecast that Solventum will post 6.27 EPS for the current fiscal year.

Solventum Company Profile

(Get Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Featured Stories

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.